Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by Fifth Third Bancorp
Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by Fifth Third Bancorp
Fifth Third Bancorp grew its holdings in Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 28.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 676 shares of the biotechnology company's stock after purchasing an additional 150 shares during the period. Fifth Third Bancorp's holdings in Axon Enterprise were worth $93,000 as of its most recent filing with the Securities & Exchange Commission.
据Five Third Bancorp在最近提交给美国证券交易委员会的13F文件中称，该公司在第一季度增持了Axon Enterprise，Inc.(纳斯达克代码：Axon-Get Rating)28.5%的股份。该基金持有这家生物技术公司676股股票，在此期间又购买了150股。截至最近提交给美国证券交易委员会(Securities&Exchange Commission)的文件，Five Third Bancorp持有的Axon Enterprise价值9.3万美元。
Several other institutional investors have also made changes to their positions in the company. Highland Capital Management LLC lifted its stake in shares of Axon Enterprise by 4.8% in the 1st quarter. Highland Capital Management LLC now owns 15,971 shares of the biotechnology company's stock valued at $2,200,000 after purchasing an additional 732 shares during the last quarter. Waypoint Capital Advisors LLC acquired a new position in shares of Axon Enterprise in the 1st quarter valued at $1,363,000. State of Alaska Department of Revenue lifted its stake in Axon Enterprise by 1.3% during the 1st quarter. State of Alaska Department of Revenue now owns 9,636 shares of the biotechnology company's stock worth $1,327,000 after acquiring an additional 120 shares in the last quarter. Yarbrough Capital LLC lifted its stake in Axon Enterprise by 28.8% during the 1st quarter. Yarbrough Capital LLC now owns 2,207 shares of the biotechnology company's stock worth $304,000 after acquiring an additional 494 shares in the last quarter. Finally, Baldwin Brothers LLC MA acquired a new position in Axon Enterprise during the 1st quarter worth about $62,000. 72.06% of the stock is currently owned by institutional investors and hedge funds.
其他几家机构投资者也对他们在该公司的头寸进行了调整。高地资本管理有限责任公司在第一季度增持了4.8%的Axon Enterprise股票。Highland Capital Management LLC现在拥有这家生物技术公司15,971股股票，价值220万美元，上个季度又购买了732股。Way Point Capital Advisors LLC在第一季度收购了Axon Enterprise的新头寸，价值1,363,000美元。阿拉斯加州税务局在第一季度增持了Axon Enterprise 1.3%的股份。阿拉斯加州税务局在上个季度增持了120股后，现在持有这家生物技术公司9636股股票，价值1,327,000美元。Yarbough Capital LLC在第一季度增持了Axon Enterprise 28.8%的股份。在上个季度增持了494股后，Yarbough Capital LLC现在持有这家生物技术公司2,207股股票，价值30.4万美元。最后，鲍德温兄弟有限责任公司在第一季度收购了Axon Enterprise的一个新头寸，价值约62,000美元。72.06%的股票目前由机构投资者和对冲基金持有。
AXON has been the topic of several research reports. Robert W. Baird decreased their target price on Axon Enterprise from $145.00 to $125.00 in a research note on Wednesday, May 11th. Morgan Stanley lowered Axon Enterprise from an "overweight" rating to an "equal weight" rating and set a $120.00 target price on the stock. in a research note on Monday, May 23rd. Credit Suisse Group initiated coverage on Axon Enterprise in a research note on Monday, May 9th. They set an "outperform" rating and a $169.00 target price on the stock. StockNews.com raised Axon Enterprise from a "hold" rating to a "buy" rating in a research note on Saturday, June 18th. Finally, Northland Securities decreased their target price on Axon Enterprise from $180.00 to $130.00 in a research note on Thursday, May 12th. One equities research analyst has rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of $172.89.
轴突一直是几份研究报告的主题。罗伯特·W·贝尔德在5月11日星期三的一份研究报告中将Axon Enterprise的目标价从145.00美元下调至125.00美元。摩根士丹利将Axon Enterprise的评级从“增持”下调至“持平”，并为该股设定120.00美元的目标价.在5月23日星期一的一份研究报告中。瑞士信贷集团在5月9日星期一的一份研究报告中启动了对Axon Enterprise的报道。他们为该股设定了“跑赢大盘”的评级和169.00美元的目标价。在6月18日星期六的一份研究报告中，StockNews.com将Axon Enterprise的评级从持有上调至买入。最后，Northland Securities在5月12日星期四的一份研究报告中将Axon Enterprise的目标价从180.00美元下调至130.00美元。一名股票研究分析师对该股的评级为持有，8名分析师给出了买入评级，一名分析师对该公司股票给予了强烈的买入评级。根据MarketBeat.com的数据，该公司目前的平均评级为买入，共识目标价为172.89美元。
Axon Enterprise (NASDAQ:AXON – Get Rating) last released its quarterly earnings data on Tuesday, May 10th. The biotechnology company reported $0.76 EPS for the quarter. Axon Enterprise had a return on equity of 3.90% and a net margin of 4.62%. The business had revenue of $256.43 million for the quarter, compared to the consensus estimate of $233.57 million. During the same quarter in the prior year, the business posted ($0.75) EPS. The business's revenue for the quarter was up 31.5% on a year-over-year basis. Equities research analysts anticipate that Axon Enterprise, Inc. will post 1.35 earnings per share for the current fiscal year.
Axon Enterprise(纳斯达克：Axon-Get Rating)最近一次发布季度收益数据是在5月10日(星期二)。这家生物技术公司公布本季度每股收益为0.76美元。Axon Enterprise的股本回报率为3.90%，净利润率为4.62%。该业务本季度的收入为2.5643亿美元，而普遍预期为2.3357亿美元。在前一年的同一季度，该业务公布了每股收益(0.75美元)。该业务当季营收较上年同期增长31.5%。股票研究分析师预计，Axon Enterprise，Inc.本财年每股收益将达到1.35美元。
In other news, Director Mark W. Kroll sold 3,159 shares of the stock in a transaction dated Wednesday, June 8th. The stock was sold at an average price of $102.82, for a total value of $324,808.38. Following the transaction, the director now owns 13,691 shares in the company, valued at approximately $1,407,708.62. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 6.90% of the company's stock.
其他新闻方面，董事马克·克罗尔在一笔日期为6月8日(星期三)的交易中出售了3159股该公司股票。这只股票的平均售价为102.82美元，总价值为324,808.38美元。交易完成后，董事现在拥有该公司13,691股股份，价值约1,407,708.62美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的，可以通过这个超级链接获得。公司内部人士持有该公司6.90%的股份。
About Axon Enterprise (Get Rating)
关于Axon Enterprise(获取评级)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Axon Enterprise，Inc.在美国和国际上以泰瑟品牌开发、制造和销售导电能源设备(CED)。它通过两个部分运作，泰瑟枪和软件和传感器。该公司还提供硬件和基于云的软件解决方案，使执法部门能够捕获、安全存储、管理、共享和分析视频和其他数字证据。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on Axon Enterprise (AXON)
- Five Below Stock is a Recession Play
- Here's How to Dollar Cost Average into Positions in a Bear Market
- MarketBeat: Week in Review 7/4 – 7/8
- Levi Strauss Proves Resilient For Dividend Investors
- AT&T (NYSE:T) Is Its Cheaper Valuation Worth A Buy?
- 免费获取StockNews.com关于Axon Enterprise(Axon)的研究报告
- 《五股之下》是一部经济衰退剧
- 以下是如何将平均成本转化为熊市头寸的方法
- MarketBeat：回顾中的一周7/4-7/8
- 列维·施特劳斯被证明对股利投资者具有弹性
- 美国电话电报公司(纽约证券交易所代码：T)较低的估值值得买入吗？
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
接受Axon企业日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收Axon Enterprise和相关公司的最新新闻和分析师评级的每日简明摘要。
译文内容由第三方软件翻译。